Comparative Efficacies of Linezolid vs. Tedizolid in an Experimental Murine Model of Vancomycin-Resistant Enterococcal (VRE) Bacteremia-Reference-Cited by-同舟云学术

Comparative Efficacies of Linezolid vs. Tedizolid in an Experimental Murine Model of Vancomycin-Resistant Enterococcal (VRE) Bacteremia

Published:2019-02-20 Issue: Volume:6 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Abdelhady Wessam,Mishra Nagendra N.

Funder

Merck

Publisher

Frontiers Media SA

Subject

General Medicine

Reference16 articles.

1. Comparison of linezolid and daptomycin in an experimental murine model of VRE faecium bacteremia; emergence of daptomycin – nonsusceptibility during daptomycin treatment;Xiong

2. Murine model of acute vancomycin-resistant enterococcal (VRE) bacteremia;Xiong

3. Results of the surveillance of tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe. Diagn;Sahm Deane;Microbiol Infect Dis,2015

4. Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content;Mishra;PLoS ONE,2012

5. Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention;Benamu;F1000 Res.,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections;Clinical Microbiology Reviews;2023-06-21

2. Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria;International Journal of Antimicrobial Agents;2023-05

3. Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA;Pharmaceutical Research;2022-11-03

4. A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model;Journal of Antimicrobial Chemotherapy;2022-06-13

5. Pharmacokinetics and Pharmacodynamics of Tedizolid;Clinical Pharmacokinetics;2022-02-07